Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 16 de 16
1.
J Phys Chem Lett ; 13(4): 1147-1158, 2022 Feb 03.
Article En | MEDLINE | ID: mdl-35084184

Bromination of high-pressure, high-temperature (HPHT) nanodiamond (ND) surfaces has not been explored and can open new avenues for increased chemical reactivity and diamond lattice covalent bond formation. The large bond dissociation energy of the diamond lattice-oxygen bond is a challenge that prevents new bonds from forming, and most researchers simply use oxygen-terminated NDs (alcohols and acids) as reactive species. In this work, we transformed a tertiary-alcohol-rich ND surface to an amine surface with ∼50% surface coverage and was limited by the initial rate of bromination. We observed that alkyl bromide moieties are highly labile on HPHT NDs and are metastable as previously found using density functional theory. The strong leaving group properties of the alkyl bromide intermediate were found to form diamond-nitrogen bonds at room temperature and without catalysts. This robust pathway to activate a chemically inert ND surface broadens the modalities for surface termination, and the unique surface properties of brominated and aminated NDs are impactful to researchers for chemically tuning diamond for quantum sensing or biolabeling applications.

2.
J Med Chem ; 60(24): 10105-10117, 2017 12 28.
Article En | MEDLINE | ID: mdl-29172484

Human insulin-like growth factor 1 (IGF-1) is a 70 amino acid protein hormone, with key impact on growth, development, and lifespan. The physiological and clinical importance of IGF-1 prompted challenging chemical and biological trials toward the development of its analogs as molecular tools for the IGF-1 receptor (IGF1-R) studies and as new therapeutics. Here, we report a new method for the total chemical synthesis of IGF-1 analogs, which entails the solid-phase synthesis of two IGF-1 precursor chains that is followed by the CuI-catalyzed azide-alkyne cycloaddition ligation and by biomimetic formation of a native pattern of disulfides. The connection of the two IGF-1 precursor chains by the triazole-containing moieties, and variation of its neighboring sequences (Arg36 and Arg37), was tolerated in IGF-1R binding and its activation. These new synthetic IGF-1 analogs are unique examples of disulfide bonds' rich proteins with intra main-chain triazole links. The methodology reported here also presents a convenient synthetic platform for the design and production of new analogs of this important human hormone with non-standard protein modifications.


Insulin-Like Growth Factor I/analogs & derivatives , Animals , Arginine/chemistry , Click Chemistry , Copper/chemistry , Cycloaddition Reaction , Disulfides/chemistry , Drug Evaluation, Preclinical/methods , Fibroblasts , Humans , Insulin-Like Growth Factor I/chemical synthesis , Insulin-Like Growth Factor I/chemistry , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor I/pharmacology , Methionine/chemistry , Mice , NIH 3T3 Cells/drug effects , Phosphorylation , Protein Domains , Proto-Oncogene Proteins c-akt/metabolism , Receptor, IGF Type 1/metabolism , Solid-Phase Synthesis Techniques , Triazoles/chemistry
3.
ACS Comb Sci ; 18(12): 710-722, 2016 12 12.
Article En | MEDLINE | ID: mdl-27936668

We designed a combinatorial library of trifunctional scaffold-derived compounds, which were derivatized with 30 different in-house-made azides. The compounds were proposed to mimic insulin receptor (IR)-binding epitopes in the insulin molecule and bind to and activate this receptor. This work has enabled us to test our synthetic and biological methodology and to prove its robustness and reliability for the solid-phase synthesis and testing of combinatorial libraries of the trifunctional scaffold-derived compounds. Our effort resulted in the discovery of two compounds, which were able to weakly induce the autophosphorylation of IR and weakly bind to this receptor at a 0.1 mM concentration. Despite these modest biological results, which well document the well-known difficulty in modulating protein-protein interactions, this study represents a unique example of targeting the IR with a set of nonpeptide compounds that were specifically designed and synthesized for this purpose. We believe that this work can open new perspectives for the development of next-generation insulin mimetics based on the scaffold structure.


Combinatorial Chemistry Techniques , Receptor, Insulin/chemistry , Receptor, Insulin/metabolism , Small Molecule Libraries/chemistry , Small Molecule Libraries/chemical synthesis , Azides/chemical synthesis , Azides/chemistry , Chromatography, High Pressure Liquid/methods , Copper/analysis , Insulin/analogs & derivatives , Insulin/chemistry , Insulin/metabolism , Molecular Structure , Protein Binding , Reproducibility of Results , Small Molecule Libraries/metabolism , Small Molecule Libraries/pharmacology , Solid-Phase Synthesis Techniques
4.
Biochemistry ; 55(21): 2903-13, 2016 05 31.
Article En | MEDLINE | ID: mdl-27171135

Insulin, insulin-like growth factors 1 and 2 (IGF-1 and -2, respectively), and their receptors (IR and IGF-1R) are the key elements of a complex hormonal system that is essential for the development and functioning of humans. The C and D domains of IGFs (absent in insulin) likely play important roles in the differential binding of IGF-1 and -2 to IGF-1R and to the isoforms of IR (IR-A and IR-B) and specific activation of these receptors. Here, we attempted to probe the impact of IGF-1 and IGF-2 D domains (DI and DII, respectively) and the IGF-2 C domain (CII) on the receptor specificity of these hormones. For this, we made two types of insulin hybrid analogues: (i) with the C-terminus of the insulin A chain extended by the amino acids from the DI and DII domains and (ii) with the C-terminus of the insulin B chain extended by some amino acids derived from the CII domain. The receptor binding affinities of these analogues and their receptor autophosphorylation potentials were characterized. Our results indicate that the DI domain has a more negative impact than the DII domain does on binding to IR, and that the DI domain Pro-Leu-Lys residues are important factors for a different IR-A versus IR-B binding affinity of IGF-1. We also showed that the additions of amino acids that partially "mimic" the CII domain, to the C-terminus of the insulin B chain, change the binding and autophosphorylation specificity of insulin in favor of the "metabolic" IR-B isoform. This opens new venues for rational enhancement of insulin IR-B specificity by modifications beyond the C-terminus of its B chain.


Hypoglycemic Agents/metabolism , Insulin-Like Growth Factor II/metabolism , Insulin-Like Growth Factor I/metabolism , Insulin/metabolism , Molecular Probes/metabolism , Receptor, IGF Type 1/metabolism , Receptor, Insulin/metabolism , Amino Acid Sequence , Animals , Cells, Cultured , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Fibroblasts/cytology , Fibroblasts/metabolism , Humans , Lymphocytes/cytology , Lymphocytes/metabolism , Mice , Mice, Knockout , Phosphorylation , Protein Binding , Protein Conformation , Sequence Homology, Amino Acid
5.
Sci Rep ; 6: 19431, 2016 Jan 21.
Article En | MEDLINE | ID: mdl-26792393

Insulin is a key hormone of human metabolism with major therapeutic importance for both types of diabetes. New insulin analogues with more physiological profiles and better glycemic control are needed, especially analogues that preferentially bind to the metabolic B-isoform of insulin receptor (IR-B). Here, we aimed to stabilize and modulate the receptor-compatible conformation of insulin by covalent intra-chain crosslinking within its B22-B30 segment, using the Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition reaction of azides and alkynes. This approach resulted in 14 new, systematically crosslinked insulin analogues whose structures and functions were extensively characterized and correlated. One of the analogues, containing a B26-B29 triazole bridge, was highly active in binding to both IR isoforms, with a significant preference for IR-B. Our results demonstrate the potential of chemistry-driven modulation of insulin function, also shedding new light on the functional importance of hormone's B-chain C-terminus for its IR-B specificity.


Insulin/chemistry , Insulin/metabolism , Receptor, Insulin/chemistry , Receptor, Insulin/metabolism , Alkynes/chemistry , Azides/chemistry , Cycloaddition Reaction , Humans , Models, Molecular , Protein Binding , Protein Conformation , Protein Isoforms , Protein Stability , Receptor, IGF Type 1/chemistry , Receptor, IGF Type 1/metabolism , Structure-Activity Relationship
6.
Molecules ; 20(10): 19310-29, 2015 Oct 23.
Article En | MEDLINE | ID: mdl-26512633

We present a trifunctional scaffold designed for the solid-phase synthesis of trimodal compounds. This scaffold holds two alkyne arms in a free and TIPS-protected form for consecutive CuAAC (copper(I)-catalyzed azide-alkyne cycloaddition), one Fmoc-protected hydrazide arm for reaction with aldehydes, and one carboxylic acid arm with CF2 groups for attachment to the resin and (19)F-NMR quantification. This scaffold was attached to a resin and derivatized with model azides and aliphatic, electron-rich or electron-poor aromatic aldehydes. We identified several limitations of the scaffold caused by the instability of hydrazones in acidic conditions, in the presence of copper during CuAAC, and when copper accumulated in the resin. We successfully overcame these drawbacks by optimizing synthetic conditions for the derivatization of the scaffold with aromatic aldehydes. Overall, the new trifunctional scaffold combines CuAAC and hydrazone chemistries, offering a broader chemical space for the development of bioactive compounds.


Copper/chemistry , Hydrazones/chemistry , Azides/chemistry , Catalysis , Click Chemistry , Cycloaddition Reaction , Molecular Mimicry , Polyethylene Glycols/chemistry , Solid-Phase Synthesis Techniques
7.
Nat Chem ; 7(3): 250-4, 2015 Mar.
Article En | MEDLINE | ID: mdl-25698335

Alkali metals can react explosively with water and it is textbook knowledge that this vigorous behaviour results from heat release, steam formation and ignition of the hydrogen gas that is produced. Here we suggest that the initial process enabling the alkali metal explosion in water is, however, of a completely different nature. High-speed camera imaging of liquid drops of a sodium/potassium alloy in water reveals submillisecond formation of metal spikes that protrude from the surface of the drop. Molecular dynamics simulations demonstrate that on immersion in water there is an almost immediate release of electrons from the metal surface. The system thus quickly reaches the Rayleigh instability limit, which leads to a 'coulomb explosion' of the alkali metal drop. Consequently, a new metal surface in contact with water is formed, which explains why the reaction does not become self-quenched by its products, but can rather lead to explosive behaviour.

8.
Anal Biochem ; 467: 4-13, 2014 Dec 15.
Article En | MEDLINE | ID: mdl-25205653

Thirteen mono-N-acyl derivatives of 2,6-diaminopimelic acid (DAP)-new potential inhibitors of the dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18)-were analyzed and characterized by infrared (IR) and nuclear magnetic resonance (NMR) spectroscopies and two capillary electromigration methods: capillary zone electrophoresis (CZE) and micellar electrokinetic chromatography (MEKC). Structural features of DAP derivatives were characterized by IR and NMR spectroscopies, whereas CZE and MEKC were applied to evaluate their purity and to investigate their electromigration properties. Effective electrophoretic mobilities of these compounds were determined by CZE in acidic and alkaline background electrolytes (BGEs) and by MEKC in acidic and alkaline BGEs containing a pseudostationary phase of anionic detergent sodium dodecyl sulfate (SDS) or cationic detergent cetyltrimethylammonium bromide (CTAB). The best separation of DAP derivatives, including diastereomers of some of them, was achieved by MEKC in an acidic BGE (500 mM acetic acid [pH 2.54] and 60mM SDS). All DAP derivatives were examined for their ability to inhibit catalytic activity of DapE from Haemophilus influenzae (HiDapE) and ArgE from Escherichia coli (EcArgE). None of these DAP derivatives worked as an effective inhibitor of HiDapE, but one derivative-N-fumaryl, Me-ester-DAP-was found to be a moderate inhibitor of EcArgE, thereby providing a promising lead structure for further studies on ArgE inhibitors.


Amidohydrolases/antagonists & inhibitors , Diaminopimelic Acid/chemistry , Electrophoresis, Capillary/methods , Enzyme Inhibitors/pharmacology , Magnetic Resonance Spectroscopy/methods , Spectrophotometry, Infrared/methods , Enzyme Inhibitors/chemistry , Escherichia coli/enzymology , Haemophilus influenzae/enzymology
9.
Eur J Med Chem ; 65: 256-75, 2013 Jul.
Article En | MEDLINE | ID: mdl-23727536

Betaine-homocysteine S-methyltransferase (BHMT) is an important zinc-dependent methyltransferase that uses betaine as the methyl donor for the remethylation of homocysteine to form methionine. In the liver, BHMT performs to half of the homocysteine remethylation. In this study, we systematically investigated the tolerance of the enzyme for modifications at the "homocysteine" part of the previously reported potent inhibitor (R,S)-5-(3-amino-3-carboxy-propylsulfanyl)-pentanoic acid (1). In the new compounds, which are S-alkylated homocysteine derivatives, we replaced the carboxylic group in the "homocysteine" part of inhibitor 1 with different isosteric moieties (tetrazole and oxadiazolone); we suppressed the carboxylic negative charge by amidations; we enhanced acidity by replacing the carboxylate with phosphonic or phosphinic acids; and we introduced pyrrolidine steric constraints. Some of these compounds display high affinity toward human BHMT and may be useful for further pharmacological studies of this enzyme. Although none of the new compounds were more potent inhibitors than the reference inhibitor 1, this study helped to completely define the structural requirements of the active site of BHMT and revealed the remarkable selectivity of the enzyme for homocysteine.


Betaine-Homocysteine S-Methyltransferase/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Pentanoic Acids/pharmacology , Sulfides/pharmacology , Betaine-Homocysteine S-Methyltransferase/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Humans , Molecular Structure , Pentanoic Acids/chemical synthesis , Pentanoic Acids/chemistry , Structure-Activity Relationship , Sulfides/chemical synthesis , Sulfides/chemistry
10.
J Med Chem ; 55(15): 6822-31, 2012 Aug 09.
Article En | MEDLINE | ID: mdl-22775318

Betaine-homocysteine S-methyltransferase 2 (BHMT-2) catalyzes the transfer of a methyl group from S-methylmethionine to l-homocysteine, yielding two molecules of l-methionine. It is one of three homocysteine methyltransferases in mammals, but its overall contribution to homocysteine remethylation and sulfur amino acid homeostasis is not known. Moreover, recombinant BHMT-2 is highly unstable, which has slowed research on its structural and catalytic properties. In this study, we have prepared the first series of BHMT-2 inhibitors to be described, and we have tested them with human recombinant BHMT-2 that has been stabilized by copurification with human recombinant BHMT. Among the compounds synthesized, (2S,8RS,11RS)-5-thia-2,11-diamino-8-methyldodecanedioic acid (11) was the most potent (K(i)(app) ∼77 nM) and selective inhibitor of BHMT-2. Compound 11 only weakly inhibited human BHMT (IC(50) about 77 µM). This compound (11) may be useful in future in vivo studies to probe the physiological significance of BHMT-2 in sulfur amino acid metabolism.


Betaine-Homocysteine S-Methyltransferase/antagonists & inhibitors , Homocysteine/analogs & derivatives , Sulfides/chemical synthesis , Betaine-Homocysteine S-Methyltransferase/chemistry , Enzyme Assays , Homocysteine/chemical synthesis , Homocysteine/chemistry , Humans , Kinetics , Recombinant Proteins/antagonists & inhibitors , Stereoisomerism , Structure-Activity Relationship , Sulfides/chemistry
11.
Magn Reson Chem ; 50(6): 415-23, 2012 Jun.
Article En | MEDLINE | ID: mdl-22539412

Tropane, tropinone, pseudopelletierine and cocaine were oxidized in situ in a nuclear magnetic resonance (NMR) tube providing mixtures of exo/endo N-oxides. Observed (13)C chemical shifts were correlated with values calculated by gauge-including atomic orbitals density functional theory (DFT) OPBE/6-31G* method using DFT B3LYP/6-31G* optimized geometries. The same method of (13)C chemical shift calculation was applied on series of methyl-substituted 1-methylpiperidines and their epimeric N-oxides described in literature. The results show that using this undemanding calculation method enables assignment of configuration of N-O group in N-epimeric saturated heterocyclic N-oxides. The approach enables assigning of the configuration with high degree of certainty even if NMR data of only one isomer are available. An improved method of in situ oxidation of starting amines in an NMR tube is also described.


Cyclic N-Oxides/chemistry , Models, Chemical , Nitrogen/chemistry , Nuclear Magnetic Resonance, Biomolecular/methods , Oxygen/chemistry , Carbon Isotopes , Cocaine/chemistry , Molecular Conformation , Oxidation-Reduction , Piperidines/chemistry , Predictive Value of Tests , Stereoisomerism , Tropanes/chemistry
12.
Bioorg Med Chem Lett ; 20(3): 862-5, 2010 Feb 01.
Article En | MEDLINE | ID: mdl-20053558

Structurally diverse, sugar-modified, thymine-containing nucleoside phosphonic acids were evaluated for their ability to inhibit thymidine phosphorylase (TP, EC 2.4.2.4) purified from spontaneous T-cell lymphomas of an inbred Sprague-Dawley rat strain. From a large set of tested compounds, among them a number of pyrrolidine-based derivatives, 10 nucleotide analogues with IC(50) values below 1 microM were selected. Out of them, four compounds strongly inhibited the enzyme with IC(50) values lying in a range of 11-45 nM. These most potent compounds might be bi-substrate analogues.


Lymphoma, T-Cell/enzymology , Nucleosides/chemistry , Organophosphonates/chemistry , Thymidine Phosphorylase/antagonists & inhibitors , Animals , Dose-Response Relationship, Drug , Humans , Inhibitory Concentration 50 , Nucleosides/pharmacology , Organophosphonates/pharmacology , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship , Thymidine Phosphorylase/metabolism
13.
J Med Chem ; 52(12): 3652-65, 2009 Jun 25.
Article En | MEDLINE | ID: mdl-19534555

Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from betaine to l-homocysteine, yielding dimethylglycine and l-methionine. In this study, we prepared a new series of BHMT inhibitors. The inhibitors were designed to mimic the hypothetical transition state of BHMT substrates and consisted of analogues with NH, N(CH(3)), or N(CH(3))(2) groups separated from the homocysteine sulfur atom by a methylene, ethylene, or a propylene spacer. Only the inhibitor with the N(CH(3)) moiety and ethylene spacer gave moderate inhibition. This result led us to prepare two inhibitors lacking a nitrogen atom in the S-linked alkyl chain: (RS,RS)-5-(3-amino-3-carboxypropylthio)-3-methylpentanoic acid and (RS)-5-(3-amino-3-carboxypropylthio)-3,3-dimethylpentanoic acid. Both of these compounds were highly potent inhibitors of BHMT. The finding that BHMT does not tolerate a true betaine mimic within these inhibitors, especially the nitrogen atom, is surprising and evokes questions about putative conformational changes of BHMT upon the binding of the substrates/products and inhibitors.


Betaine-Homocysteine S-Methyltransferase/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Homocysteine/analogs & derivatives , Pentanoic Acids/pharmacology , Drug Design , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Homocysteine/chemical synthesis , Homocysteine/chemistry , Homocysteine/pharmacology , Humans , Molecular Structure , Pentanoic Acids/chemical synthesis , Pentanoic Acids/chemistry , Stereoisomerism , Structure-Activity Relationship
14.
Nucleic Acids Symp Ser (Oxf) ; (52): 537-8, 2008.
Article En | MEDLINE | ID: mdl-18776491

Commercially available trans-4-hydroxy-L-proline has been used as a starting material for the synthesis of prolinol-based nucleotide analogues with N-phosphonomethyl moiety attached to the nitrogen atom of prolinol ring. The synthetic methodology based on the inversion of configuration at both 1- and 4- positions led, in result, to all diastereoisomeric O-protected 4-mesyloxyprolinol-N-methylphosphonates. Alkylation of nucleobases using the synthons afforded the nucleotide analogues corresponding to alpha- and beta-nucleotides in both L- and D-series. The NMR-based conformational study of alpha- and beta-nucleotides in aqueous solution performed at two different pH values securing either N-fully protonated or deprotonated forms revealed in both cases occurrence of the same mostly populated conformer. All final prolinol-based nucleoside phosphonic acids were tested for cytotoxic and antiviral properties, but no significant activity was found.


Deoxyribonucleotides/chemical synthesis , Organophosphonates/chemical synthesis , Pyrrolidines/chemistry , Deoxyribonucleotides/chemistry , Nucleosides/chemistry , Organophosphonates/chemistry
15.
Nucleic Acids Symp Ser (Oxf) ; (52): 665-6, 2008.
Article En | MEDLINE | ID: mdl-18776555

A number of structurally diverse nucleoside phosphonic acids have been tested against human recombinant thymidine phosphorylase and human platelets supernatant using 2'-deoxy-5-nitrouridine as the substrate. We have selected several inhibitors working at micromolar level as lead structures for further evaluation.


Enzyme Inhibitors/chemistry , Nucleosides/chemistry , Nucleosides/pharmacology , Organophosphonates/chemistry , Thymidine Phosphorylase/antagonists & inhibitors , Animals , Blood Platelets/enzymology , CHO Cells , Cricetinae , Cricetulus , Enzyme Inhibitors/pharmacology , Humans , Structure-Activity Relationship , Thymidine Phosphorylase/chemistry
16.
Article En | MEDLINE | ID: mdl-14565345

A novel alpha- and beta-configured pyrrolidine nucleoside phosphonates in adenine series were synthesized from trans-4-hydroxy-L-proline as starting material. d(ApA) analogues were also prepared and studied with respect to their hybridization properties with polyU.


Dinucleoside Phosphates/chemistry , Nucleotides/chemical synthesis , Organophosphonates/chemistry , Pyrrolidines/chemistry , Adenosine/chemistry , Binding Sites , Hydroxyproline , Indicators and Reagents , Nucleotides/chemistry , Oligonucleotides/chemical synthesis , Poly U/chemistry , Stereoisomerism
...